Dapagliflozin has 6 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Insulin Human, Sulfonylurea, Lithium. Patients taking Dapagliflozin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 6
- Major
- 2
- Moderate
- 1
Major (2)
- Dapagliflozin + Insulin Human— Risk of hypoglycemia may be increased when dapagliflozin is used concomitantly with insulin. Concomitant use may require…
- Dapagliflozin + Sulfonylurea— Risk of hypoglycemia may be increased when dapagliflozin is used concomitantly with sulfonylurea insulin secretagogues. …
Moderate (1)
- Dapagliflozin + Lithium— Concomitant use of dapagliflozin with lithium may decrease serum lithium concentrations. Monitor serum lithium concentra…